Bovine Colostrum Increases Pore-Forming Claudin-2 Protein Expression but Paradoxically Not Ion Permeability Possibly by a Change of the Intestinal Cytokine Milieu

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Bodammer, Peggy ^a,b   Kerkhoff, Claus ^a   Maletzki, Claudia ^b   Lamprecht, Georg ^b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 10; CLAUDIN 15; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TIGHT JUNCTION PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CLAUDIN 2 GENE; COLON MUCOSA; COLOSTRUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; FEMALE; ILEUM MUCOSA; ION PERMEABILITY; LONG TERM EXPOSURE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION;

ANIMALS; ANIMALS, OUTBRED STRAINS; CACO-2 CELLS; CATTLE; CLAUDINS; COLOSTRUM; CYTOKINES; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; FEMALE; HUMANS; ILEUM; INTERLEUKIN-6; MICE; PERMEABILITY; PREGNANCY;

EID: 84878162324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064210     Document Type: Article

References (43)

1. Gallo RL, Hooper LV (2012) Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 12, 503-16.
2. Suzuki T (2012) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci.
3. Tsukita S, Yamazaki Y, Katsuno T, Tamura A (2008) Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27, 6930-8.
4. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, et al. (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123, 1777-88.
5. Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336, 1268-73.
6. Magrone T, Jirillo E (2013) The interplay between the gut immune system and microbiota in health and disease: Nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 19, 1329-42.
7. Gruber L, Lichti P, Rath E, Haller D (2012) Nutrigenomics and nutrigenetics in inflammatory bowel diseases. J Clin Gastroenterol 46, 735-47.
8. Cabre E, Domenech E (2012) Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol 18, 3814-22.
9. Amasheh M, Andres S, Amasheh S, Fromm M, Schulzke JD (2009) Barrier effects of nutritional factors. Ann N Y Acad Sci 1165, 267-73.
10. Langmead L, Rampton DS (2006) Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 23, 341-9.
11. Playford RJ, Macdonald CE, Johnson WS (2000) Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 72, 5-14.
12. Solomons NW (2002) Modulation of the immune system and the response against pathogens with bovine colostrum concentrates. Eur J Clin Nutr 56 Suppl 3, S24-8.
13. Playford RJ, MacDonald CE, Calnan DP, Floyd DN, Podas T, et al. (2001) Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) 100, 627-33.
14. Playford RJ, Floyd DN, Macdonald CE, Calnan DP, Adenekan RO, et al. (1999) Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44, 653-8.
15. Khan Z, Macdonald C, Wicks AC, Holt MP, Floyd D, et al. (2002) Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study. Aliment Pharmacol Ther 16, 1917-22.
16. Bodammer P, Maletzki C, Waitz G, Emmrich J (2011) Prophylactic application of bovine colostrum ameliorates murine colitis via induction of immunoregulatory cells. J Nutr 141, 1056-61.
17. Soderholm JD, Olaison G, Peterson KH, Franzen LE, Lindmark T, et al. (2002) Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 50, 307-13.
18. Zeissig, S Bürgel N, Günzel D, Richter J, Mankertz J, et al. (2007) Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56, 61-72.
19. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, et al. (2002) Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115, 4969-76.
20. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, et al. (2010) Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 123, 1913-21.
21. Krug SM, Gunzel D, Conrad MP, Lee IF, Amasheh S, et al. (2012) Charge-selective claudin channels. Ann N Y Acad Sci 1257, 20-8.
22. Suzuki T, Yoshinaga N, Tanabe S (2011) Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286, 31263-71.
23. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR (2008) Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 88, 1110-20.
24. Heller F, Florian P, Bojarski C, Richter J, Christ M, et al. (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550-64.
25. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, et al. (1999) Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112 (Pt 1), 137-46.
26. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, et al. (2010) TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci 123, 4145-55.
27. Oshima T, Miwa H, Joh T (2008) Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol 23 Suppl 2, S146-50.
28. Howe KL, Reardon C, Wang A, Nazli A, McKay DM (2005) Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol 167, 1587-97.
29. Shen L, Weber CR, Turner JR (2008) The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol 181, 683-95.
30. Chalmers AD, Whitley P (2012) Continuous endocytic recycling of tight junction proteins: how and why? Essays Biochem 53, 41-54.
31. Wapenaar MC, Monsuur AJ, van Bodegraven AA, Weersma RK, Bevova MR et al (2008) Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 57, 463-7.
32. Jorgensen AL, Juul-Madsen HR, Stagsted J (2010) Colostrum and bioactive, colostral peptides differentially modulate the innate immune response of intestinal epithelial cells. J Pept Sci 16, 21-30.
33. Labeta MO, Vidal K, Nores JE, Arias M, Vita N, et al. (2000) Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med 191, 1807-12.
34. Filipp D, Alizadeh-Khiavi K, Richardson C, Palma A, Paredes N, et al. (2001) Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proc Natl Acad Sci U S A 98, 603-8.
35. Bode L (2009) Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 67 Suppl 2, S183-91.
36. Hurley WL, Theil PK (2011) Perspectives on immunoglobulins in colostrum and milk. Nutrients 3, 442-74.
37. Newburg DS, Walker WA (2007) Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 61, 2-8.
38. Bodammer P, Zirzow E, Klammt S, Maletzki C, Kerkhoff C (2013) Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin. BMC Immunol 14, 10.
39. Shing CM, Peake JM, Suzuki K, Jenkins DG, Coombes JS (2009) Bovine colostrum modulates cytokine production in human peripheral blood mononuclear cells stimulated with lipopolysaccharide and phytohemagglutinin. J Interferon Cytokine Res 29, 37-44.
40. Jenny M, Pedersen NR, Hidayat BJ, Schennach H, Fuchs D (2010) Bovine colostrum modulates immune activation cascades in human peripheral blood mononuclear cells in vitro. New Microbiol 33, 129-35.
41. Biswas P, Vecchi A, Mantegani P, Mantelli B, Fortis C, et al. (2007) Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cells. New Microbiol 30, 447-54.
42. Arnott ID, Watts D, Ghosh S (2002) Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease? Aliment Pharmacol Ther 16, 857-67.
43. Feagins LA, Cryer BL (2010) Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease? Dig Dis Sci 55, 226-32.